Structural and functional details of the N-terminal activation function 1 (AF1) of most nuclear receptors are poorly understood due to the highly dynamic intrinsically disordered nature of this domain. A hydrogen/deuterium exchange (HDX) mass-spectrometry-based investigation of TATA box-binding protein (TBP) interaction with various domains of progesterone receptor (PR) demonstrate that agonist-bound PR interaction with TBP via AF1 impacts the mobility of the C-terminal AF2. Results from HDX and other biophysical studies involving agonist-and antagonist-bound full-length PR and isolated PR domains reveal the molecular mechanism underlying synergistic transcriptional activation mediated by AF1 and AF2, dominance of PR-B isoform over PR-A, and the necessity of AF2 for full AF1-mediated transcriptional activity. These results provide a comprehensive picture elaborating the underlying mechanism of PR-TBP interactions as a model for studying nuclear receptor (NR)-transcription factor functional interactions.
INTRODUCTION
The progesterone receptor (PR) is the cognate steroid receptor (SR) for the hormone progesterone belonging to the nuclear receptor (NR) superfamily. This receptor plays a pivotal role in a range of biological functions, including development and maintenance of female reproductive tissue (Anderson and Clarke, 2004; Graham and Clarke, 1997; Li and O'Malley, 2003; Obr and Edwards, 2012 ). There are two major isoforms of PR, PR-A and PR-B, with the latter having extra 164 amino acids at the N terminus. For a majority of PR target genes, PR-B is a more potent transcriptional activator as compared to PR-A (Tung et al., 1993; Vegeto et al., 1993) . The functional differences and tissue specificity of both isoforms are evident from knockout studies in mice (Fernandez-Valdivia et al., 2005) . It has been reported that, in breast cancer cells, the majority of PR target genes are regulated by the B isoform (Mote et al., 1999 (Mote et al., , 2002 Richer et al., 2002) .
Steroid NRs are multidomain proteins containing an N-terminal domain (NTD), DNA-binding domain (DBD), hinge region, and a C-terminal ligand-binding domain (LBD) . Both the LBD and DBD of PR and other SRs are globular in nature, and they have been well studied by a wide range of structural techniques. Moreover, several cocrystal structures of ligand-bound LBD in complex with coregulatory peptides have been solved (Bledsoe et al., 2002; Brzozowski et al., 1997; Madauss et al., 2007; Raaijmakers et al., 2009; Shiau et al., 1998; Williams and Sigler, 1998) . Typical of SRs, PR consists of an unusually large intrinsically disordered (ID) NTD that comprises nearly half of the receptor. PR contains two activation function domains (AF1 and AF2) that provide interaction surfaces for transcriptional coregulatory proteins to bind. The N-terminal AF1 is ligand-independent, whereas the C-terminal AF2 is ligand-dependent. Unfortunately, no high-resolution structures of full-length SRs have been reported, partly due to the highly disordered nature of their NTDs (Hill et al., 2012; Khan et al., 2012; Kumar and McEwan, 2012; Kumar and Thompson, 2012; McEwan et al., 2007) . Thus, efforts to develop steroid receptor modulators (SRMs) for endocrinebased therapies have been mostly based on their ability to modulate AF2/LBD surfaces for coregulatory protein interactions, thus neglecting the AF1/NTD despite the fact that this region of SRs contributes significantly to the transcriptional activity of these receptors.
Despite the lack of defined structure, ID regions of proteins are known to play important roles in molecular recognition and assembly formations. They carry out functions through a process called coupled binding and folding, where upon interaction with its target binding partner, the ID protein or region undergoes a disorder-ordered transition (Dyson and Wright, 2002; Wright and Dyson, 2009) . Consistent with this, a core C-terminal domain of the transcription factor TBP (TBP c ; amino acids [aas] 159-339) has been reported to bind and fold the AF1/NTD regions of several SRs by promoting the ordered structure formation that facilitates AF1-mediated activity (Khan et al., 2011; Kumar et al., 2004 Kumar et al., , 2013 Wä rnmark et al., 2001) . In a recent report, we demonstrated a subregion of PR AF1/NTD (aas 350-428) is required for TBP c binding and TBP c -dependent PR transcriptional activation (Kumar et al., 2013 ). However, these previous studies have examined the influence of TBP on structure and folding of isolated NTDs and thus do not account for mechanisms and potential conformational flexibility associated with interdomain interactions of full-length receptors. It has been suggested that SRs are dynamic ensembles of structures responding to a variety of target molecules via synergistic actions of AF1 and AF2. Both the AFs are regulated through allosteric coupling to produce differential selection and/or activation of gene expression (Billas and Moras, 2013; Hilser and Thompson, 2011) . However, direct detection of coordinated actions of AF1 and AF2 to bring about synergistic effects on gene activation remains elusive (Tetel et al., 1999; Tung et al., 2006) .
Because AF1/NTDs have eluded crystallization and no highresolution structures have been obtained of intact SRs, several groups have applied solution phase techniques to study SR structures, including the use of hydrogen/deuterium exchange mass spectrometry (HDX-MS). HDX-MS has emerged as a powerful technique to characterize conformational flexibility associated with protein-protein or protein-ligand interaction in solution state (Chalmers et al., 2006; Englander, 2006; Konermann et al., 2011; Landgraf et al., 2013; Zhang et al., 2014) . HDX-MS has advantages for large molecular proteins such as SRs because it is not limited by protein size and can localize changes in conformational flexibility to specific sequences. This technique has been used previously to characterize NRs' interaction with other binding partners and small-moleculedependent activation mechanisms Dai et al., 2009; Devarakonda et al., 2011; Goswami et al., 2013; Harms et al., 2013; Zhang et al., 2011) . Here, we report the use of HDX-MS to provide an analysis of the solution state flexibility of full-length PR-A and PR-B and the conformational ensemble of PR upon binding the coregulatory protein TBP and hormonal agonist and antagonist ligands. These studies demonstrate that, although TBP directly binds PR through AF1/NTD, conformational rearrangements in the intact PR involve both AF1/NTD and AF2/LBD, indicating intramolecular interdomain interactions. Changes in structural flexibility in regions of TBP were also observed upon interaction with PR-NTD/AF1, indicating the potential of the NTD/AF1 to modulate conformation and activity of coregulatory proteins.
RESULTS

Sequence Coverage of Full-Length Progesterone Receptor
Intact PR-A and PR-B complexed with either hormone agonist ligand (R5020) or antagonist (RU486) were expressed in the baculovirus insect cell system and purified to near homogeneity as previously described (Kumar et al., 2013; Wardell et al., 2005) . Purified full-length PR-A and PR-B have previously been shown by biochemical and biophysical analyses to form dimers in solution in the absence of DNA (Connaghan-Jones et al., 2006; Heneghan et al., 2005; Tetel et al., 1997) . By size-exclusion chromatography, purified PR-A and PR-B in the 1 or 2 mM range used here for HDX analysis behaved as a stable dimeric protein (data not shown). Pepsin digestion of PR-A ($750 aa) and PR-B ($930 aa) liganded with R5020 under HDX compatible conditions resulted in 75% and 78% sequence coverage, respectively (Figure S1A available online). Whereas sequence coverage of the LBD was nearly complete, sequence coverage of the heavily posttranscriptionally modified (including phosphorylation, acetylation, methylation, and others) AF1/NTD was significantly less (59% PR-A; 69% PR-B). Sequence coverage for PR-A was similar to that previously reported whereas this report is of HDX-MS of the larger full-length PR-B (Kumar et al., 2013) . As anticipated, sequence coverage decreased slightly as the perturbation map ( Figure S1B ) contains only peptides that are detected in all the injections (all 45 injections for a three-replicate experiment). Nevertheless, the overall sequence coverage is sufficient to provide meaningful insight into the flexibility of such large proteins in the 85-100 kDa range.
Conformational Flexibility of Full-Length PR and TBP c
We investigated the conformational flexibility of full-length PR-A and PR-B bound to the hormone agonist R5020, and the results are displayed in Figure 1 (also Figures S2 and S3 ). The average percentage deuterium exchange corrected for back exchange (see Experimental Procedures) over a 1 hr time period is overlaid onto the crystal structure of PR-LBD (Protein Data Bank [PDB] ID: 1A28) and PR DBD (PDB ID: 2C7A). Because no crystal structure is available containing the NTD and hinge for either PR-A or PR-B, these regions are illustrated schematically. The exchange dynamics of agonist-bound PR-B and PR-A are displayed in a sequence overlay format in Figures S2 and S3. As expected, the ID AF1/NTD and hinge domains of the receptors afforded little protection to hydrogen/deuterium (H/D) exchange whereas the folded globular DBD and LBD contain regions with significant protection to solvent exchange. Representative deuterium buildup plots for peptides from AF1/NTD show that, at the earliest time point measured (10 s), their backbone amide hydrogens are near fully exchanged with solvent ( Figure 1 ). The conformational flexibility of TBP c , expressed in bacterial cells and purified as previously described (Kumar et al., 2013) , was also examined by HDX-MS. TBP c is a folded globular structure, and thus most sequence regions are significantly protected from solvent exchange. However, TBP c contains regions that are highly dynamic and not protected to exchange ( Figure S4 ).
Influence of TBP c Interaction on Conformational
Flexibility of Intact PR Liganded with Hormone Agonist Next, we utilized differential HDX-MS to investigate the effect of TBP c interaction on conformational flexibility of the hormone agonist (R5020)-occupied intact receptor by comparing exchange kinetics in peptide regions of either PR-A or PR-B in the absence (apo) and presence of TBP c . Interaction of agonist-liganded PR-B with TBP c did not result in significant changes in HDX in any region of AF1/NTD detected. However, perturbations in exchange kinetics were observed in the carboxyl terminal LBD of the receptor. Specifically, regions in the LBD including (helix 1) H1 (aas 680-690), H9 and H10 (aas 850-870) , and H12 showed reduced solvent exchange upon interaction with TBP c . The deuterium build-up curves of selected peptides along with the differential exchange data overlaid onto the LBD crystal structure are shown in Figure 2A . AF2 is a wellstructured protein fold composed of helices 3-5 and 12 of the LBD that forms a pocket for complementary binding of LXXLL motifs of coactivators. Conformational positioning of H12 is critical for ligand-agonist-dependent activation of AF2. The strongest effect of TBP c on stabilizing deuterium exchange kinetics in the LBD was with peptides in H12, suggesting that TBP c influences this critical region of PR either directly or indirectly through allosteric interactions or through physical interactions between N and C terminus of intact PR. Similar effects of TBP c were observed on stabilizing exchange kinetics of H12 in PR-A ( Figure 2B ). Figure 2C shows a comparative view of H12 stabilization in agonist-bound PR-A and PR-B upon TBP c binding.
In previous reports, TBP c interaction with NTD of PR and other SRs was demonstrated to induce an increase in secondary structure as detected by circular dichroism spectroscopy and tertiary folding by fluorescence emission and partial proteolysis (Kumar et al., 2004 (Kumar et al., , 2013 Kumar and Thompson, 2012) . Therefore, the failure to observe significant changes in HDX kinetics within AF1/NTD upon interaction with TBP c was somewhat unexpected but may be due in part to the highly dynamic nature of this domain. The deuterium build-up curves from NTD ( Figure 1) show most of the amide hydrogens are fully exchanged at the earliest time point (10 s) measured. Thus, it is possible that helical structures or tertiary folding detected by other methods within the NTD upon interaction with TBP c (Khan et al., 2012; Kumar et al., 2013) interconverts to unstructured conformers at a time scale faster than 10 s. This phenomenon of transient ''coupled folding and binding'' process, where an intrinsically disordered protein (IDP) undergoes disorderorder transition upon interaction with a folded binding partner, has been reported (Wright and Dyson, 2009) . Previously, we reported a strategy to characterize the transient protein-protein interaction involving an IDP and its folded binding partner by lowering the exchange pH and in turn expanding the time window to the millisecond level . Appling a similar approach here (interaction tested at pH 6.0) did not result in a perturbation in HDX kinetics upon TBP c interaction for any peptide detected from the AF1/NTD of hormone agonist-bound full-length PR. It is possible that the affinity between PR and TBP c of 0.17 mM at pH 7.5 (Kumar et al., 2013) is reduced further at pH 6.0. Another possibility is that the sequence region that undergoes change in conformation may be in a region that is not covered by MS/MS sequencing in HDX experimental conditions ( Figure S1 ). To further address Agonist (R5020)-bound full-length PR-B was analyzed by hydrogen deuterium exchange studies and the average percentage of deuterium incorporation across six different time points (0, 10, 30, 60, 300, 900, and 3,600 s) is overlaid onto the crystal structure of PR-LBD (PDB ID: 1A28) and PR-DBD (PDB ID: 2C7A). The color is according to the color code at the bottom of the figure. The hinge region and N-terminal domain are represented by schematics due to lack of atomic structure. Representative peptide deuterium build-up curves from each domain are indicated at top. Error bars are plotted using GraphPad Prism software and computed by HDX WorkBench software (Pascal et al., 2012) .
this, we used a fragment of PR with truncation of NTD to aa 233 that is a shortened version of PR-A lacking an additional 68 aa from the N terminus. Differential HDX-MS was performed with this 233-PR in the presence and absence of TBP c . TBP c interaction failed to affect exchange in any regions of NTD and resulted in protection to solvent exchange in AF2, with the magnitude of protection being similar to that observed for TBP c interaction with PR-A ( Figure 2D ). Similarity of results with PR-A and 233-PR further emphasizes the importance of the N-terminal sequence of PR-B as responsible for stronger effect of TBP c on structural flexibility in the AF2 LBD and that failure to detect perturbation in NTD is likely due to transient nature of stabilized structure.
TBP Interaction with Antagonist Liganded PR Next, we investigated the interaction of TBP c with antagonistbound PR. Previous crystallography and other protein biophysical methods have shown a significant change in conformation of H12 of PR LBD upon binding the antagonist RU486 versus hormone agonist (Raaijmakers et al., 2009; Vegeto et al., 1993; Weigel et al., 1992) . Interestingly, TBP c interaction with RU486-liganded PR did not result in changes in the HDX kinetics in H12 or other helices of the LBD ( Figures 3A and 3B ). However, unlike that observed for agonist-bound receptor, TBP c interaction with RU486-liganded PR resulted in a slight but statistically significant increase in solvent exchange in the region containing aas 319-328 within the AF1/NTD of both PR-A and PR-B. This 
HDX of TBP c in the Presence and Absence of PR
Results from HDX analysis of the isolated AF1/NTD of PR in the presence and absence of TBP c failed to detect any footprint on NTD and hence was consistent with the data obtained using full-length receptor ( Figure S5 ). Therefore, we investigated the impact of AF1/NTD interaction on the conformational flexibility of TBP c by analyzing the differential HDX kinetics of TBP c in the presence and absence of these domains. These experiments were performed with both isolated NTDs and full-length receptors. Results demonstrate that the isolated AF1/NTDs of PR-A and PR-B interact directly with TBP c , with the AF1/NTD of PR-B inducing more stabilization of TBP c when compared to AF1/NTD of PR-A ( Figures 4A and 4B ). The region of TBP c containing aas 243-253 was stabilized by both NTDs; however, interaction with PR-B AF1/NTD resulted in additional regions being protected from solvent exchange (aas 275-290), suggesting that AF1/NTD of PR-B makes a stronger interaction with TBP c as compared with the NTD of PR-A. Full-length PR-B induced greater perturbation of exchange on TBP c than PR-A ( Figures 4C and 4D ), an observation that is consistent with HDX data obtained on the isolated AF1/ NTDs. However, closer inspection of the data shows additional regions within TBP c are influenced in the presence of full-length PR-B as compared to its isolated AF1/NTD, suggesting that there are contributions from other regions of PR-B in binding to TBP c .
Isolated PR-LBD Does Not Interact with TBP c
The observation that TBP c alters solvent exchange in both AF1/ NTD and AF2 (LBD) in the intact receptor encouraged us to investigate if the LBD alone can interact with the TBP c and if so whether this interaction can alter conformation in AF2/H12. To this end, isolated PR-LBD liganded with R5020 was analyzed by HDX in the presence and absence of TBP c . As shown in Figures 5A and 5B, no statistically significant changes in HDX kinetics were observed in either the PR-LBD or TBP c . These data indicate either a lack of direct physical interaction of TBP c with the LBD or that this interaction is not sufficient for altering conformational flexibility of either LBD/AF2 or TBP c . In previous studies with isolated PR-LBD, we were unable to detect direct binding with TBP c (Kumar et al., 2013) . These data collectively suggest that TBP c only influences the flexibility of AF2 in the context of the full-length PR and that there is no direct TBP c -AF2 interaction.
Limited Proteolysis Analysis of Intact PR versus Isolated Domains Confirms that Conformational Change Is
Dependent upon TBP c Interaction with the NTD Previously, we have shown that, when bound to TBP c , the isolated AF1/NTD of PR is protected against limited proteolysis, suggesting that TBP c binding induces a more compact tertiary structure in AF1/NTD (Kumar et al., 2013) . To determine the influence of TBP c interaction on folding of the NTD and other domains in the context of full-length PR, experiments were extended to include limited proteolysis by trypsin of full-length PR-A and isolated PR-LBD and NTD in the absence and presence of TBP c . As shown by Coomassie-stained SDS gels, isolated PR-NTD was highly susceptible to proteolysis, resulting in nearly complete degradation with little intact NTD remaining ( Figure 6A ; compare lanes 2 and 6). PR-A also showed a high susceptibility to proteolysis, except for a protected band corresponding to the size of LBD ( Figure 6A ; compare lanes 1 and 5). The isolated PR-LBD and TBP c are highly resistant to limited proteolysis ( Figure 6A ; compare lanes 3 and 7 and lanes 4 and 8, respectively), consistent with stable globular structure of these polypeptides. Limited proteolysis of mixtures of PR-A or PR-NTD and TBP c resulted in some residual intact PR-A and NTD plus smaller fragments not detected by digestion with either the PR-A or PR-NTD alone ( Figure 6A ; lanes 9 and 10). To determine whether protected fragments generated from the PR-A:TBP c mixture were coming from the PR-NTD or LBD, tryptic digests were also analyzed by immunoblotting with monoclonal antibodies (clones 1294 and 636) to different epitopes within the PR-NTD ( Figure 6B , upper and middle panels) or the C terminus of PR-LBD (clone 10A9; Figure 6B , lower panel). Digests of PR-A in the absence of TBP c showed a few fragments larger than LBD that are reactive with NTD-specific monoclonal antibodies (mAbs) (1294 and 636) plus a predominant protected protein band the size of the LBD ($27 kDa) that was reactive only with the C-terminal-specific mAb (10A9; Figures 4 and 6B) . As expected, digests of NTD alone generated only trace protected bands reactive with NTD-specific mAbs and none that are reactive with the LBD specific mAb ( Figure 6B ; lane 5). When PR-A or PR-NTD and TBP c were mixed together, several different protected PR fragments were detected with the PR-NTD-specific mAbs and the patterns were distinct, with each antibody indicating that multiple sites within the NTD change their accessibility to trypsin in the presence of TBP c ( Figure 6B ; compare lanes 4 and 7 and 5 and 8, respectively). Protection against partial proteolysis indicates that the NTD folds into a more compact conformation in the context of intact PR-A when complexed with TBP c . Analysis of PR-A digests in the presence TBP c with the PR-LBD-specific mAb (10A9) showed an increase in relative amount of intact PR-A, a stronger protected band corresponding to LBD, plus several predominant unique fragments between the size of intact PR and the LBD not detected in the absence of TBP c ( Figure 6B ; compare lanes 4 and 7). As expected, no bands were detected with the LBDspecific mAb (10A9) with digests of the NTD either in the absence or presence of TBP c ( Figure 6B ; lanes 5 and 8). These results are consistent with regions of both the NTD and LBD undergoing protection from limited proteolysis when intact PR-A is complexed with TBP c .
We previously showed that TBP c directly binds to NTD and not LBD in vitro (Kumar et al., 2013) ; therefore, we carried out another set of experiments to confirm that the conformational changes observed in the PR-LBD are as a result of direct NTD-TBP c binding in the full-length receptor. Because no detectable cleavage of PR-LBD alone was detected under conditions above ( Figures 6A and 6B) , we carried out limited tryptic digestion of PR-LBD with and without TBP c at room temperature for 10, 15, and 20 min to allow a higher degree of digestion and resolved the products of digestion by immunoblot with the PR-LBDspecific antibody. As expected, a strong reaction for intact PR-LBD was seen with the antibody (Figure 6C ; lane 1) with no reaction with TBP c . Under these conditions, several smaller protected fragments of PR-LBD were generated by limited digestion at each time point and there were no evident differences in the patterns of LBD cleavage in the absence or presence of TBP c ( Figure 6C ). These results demonstrate that protection from proteolysis in the LBD in the presence of TBP occurs only with intact PR-A and not with the isolated LBD ( Figure 6B , lower panel), indicating this effect on structure in the LBD is dependent on NTD-TBP c interaction and an interdomain communication.
DISCUSSION
The strategy for the development of structure-based SR modulators has focused largely on ligand control of AF2, despite the fact that the AF1/NTD region of SRs contribute significantly to the receptor's transcriptional activity, and functional synergy between AF1 and AF2 is essential to SR-mediated target gene regulation. This is not surprising due to the limited knowledge about the structure and conformational flexibility of AF1-AF2 interaction within full-length SRs. Similarly, there is lack of structural insight into coregulatory protein interactions with AF1/NTD. It is generally thought that the ID nature of AF1/NTD enables this region of the receptor to adapt different structures depending on the context of the interacting partner. This structural plasticity likely contributes to the functional diversity of the receptor and may provide a strategy to modulate target-gene-promoter-or tissue-specific effects.
Previous reports demonstrate that TBP c binding with the NTD of steroid receptors induces secondary structure within AF1/ NTD by coupled binding and folding mechanism (Fischer et ). Based on deletion mutation experiments, a subregion of PR-AF1/ NTD (aas 350-428) has been identified to undergo disorder-order conformational transition upon its interaction with TBP, and in cell transfection assays, this subregion was also required for TBP c enhancement of AF1/NTD-dependent transcriptional activity (Kumar et al., 2013) . In addition to independent effects of TBP on structure and function of the isolated PR-NTD, effects of TBP on hormone-dependent AF2 activity in the context of full-length PR were previously observed. With a constitutively active two-domain PR-DBD/AF1-NTD construct that lacks LBD/AF2, deletion of aas 323-427 of the NTD completely abrogated TBP stimulation of AF1/NTD-mediated transcriptional activity, whereas deletion of this same region in full-length PR-B only partially reduced TBP-dependent hormone-induced transcriptional activation (Kumar et al., 2013) . These functional data suggested to us that TBP-induced folding of the NTD has the potential to mediate an allosteric interdomain interaction, thus prompting HDX-MS analysis to further explore this question.
HDX-MS has been used to probe the conformational flexibility of intact multidomain proteins in solution, even in the absence of a high-resolution atomic structure, and has the potential to detect long-range allosteric effects (Zhang et al., 2011) . In this study, we applied HDX to probe the conformational flexibility of intact PR-A and PR-B. As expected, the HDX results show that AF1/NTD of both PR isoforms is highly dynamic as compared to the DBD and LBD for both agonist-and antagonist-bound receptor. In both receptor isoforms, the hinge region appears to be unstructured as well, as determined by rapid deuterium incorporation in peptides representative of this domain. These observations are consistent with another report on full-length nuclear receptors (Chandra et al., 2008) . Our present study shows that full-length PR-B (bound to hormone agonist) has higher degree of stabilization at helix 12 and more perturbation sites compared to PR-A upon interaction with TBP c (Figures 2A-2C ). Isolated NTDs of PR-A and PR-B follow the same norm ( Figures 4A and 4B) . Moreover, when the first 232 aa of PR-B NTD is deleted, it shows a more PR-A-like interaction with TBP ( Figure 2D ). Considering all these observations of higher global protection in PR-B-TBP c interactions, our HDX study supports previous findings that PR-B is the dominant transcription activator and acts through a distinct structural conformation of the NTD of B isoform than that of the PR-A isoform (Bain et al., 2001; Hill et al., 2012; Tung et al., 2006) .
Despite the fact that TBP c interaction with isolated AF1/NTDs of PR (and other SRs) has been demonstrated to induce a stabilization of secondary helical structure and folding by other biophysical methods, we were not able to detect TPB c -dependent protection to solvent exchange in AF1/NTD in the context of either the intact PR (Figures 2 and 3) or the isolated NTD (Figure S5 ). This apparent discrepancy is likely due to the extreme flexibility and disorder of the NTD and to the transient nature of TBP c -induced folded structures that may not be detectable in the time frame of the HD exchange kinetics. Interaction of the TIF2 coactivator with AF1 of glucocorticoid receptor (GR) gave similar results wherein HDX-MS was unable to detect changes in conformational flexibility, whereas other biophysical methods detected structural changes (Khan et al., 2012) . Interestingly, we were able to detect perturbation in HDX kinetics of TBP c upon interaction with either the isolated AF1/NTD or full-length PR ( Figures 4A and 4B) . Additionally, both full-length PR-B and the isolated NTD of PR-B gave stronger interactions and effects on stabilizing structural conformations of TBP c than either intact PR-A or isolated NTD, respectively, of PR-A (Figure 4) . These results indicate that the AF1/NTD can affect structural conformation of an interacting protein and may be a mechanism by which the intrinsically disordered AF1/NTD can affect activity of coregulatory proteins associated with receptors. Another finding of this study was that TBP c interaction mediated stabilization of AF2/LBD but only through interaction with NTD of the intact PR occupied with hormone agonist. Additionally, the magnitude of perturbation of AF2 conformation and number of protected sites was greater with PR-B than PR-A (Figure 2) . Consistent with previous reports that TBP c binds only to NTD and not with LBD (Kumar et al., 2013) , no change in HD exchange kinetics was observed with either an isolated PR-LBD (+ hinge) or TBP c when incubated together ( Figure 5 ). With intact PR (either isoform) bound to the hormone antagonist (RU486), TBP c -induced perturbation of AF2/LBD was prevented and unique perturbation of a short region between aas 319 and 328 within AF1/NTD was observed (Figure 3) . These data collectively support the conclusion that TBP interaction with AF1/NTD impacts the AF2 surface via long-range allostery or that binding TBP alters the proximity of AF1/NTD to AF2/LBD within the intact receptor. Physical interaction between AF1 and AF2, both in vivo and in vitro, has been reported before (Tetel et al., 1999) , resulting in a functional synergy between AF1 and AF2 that is an essential component of SR-mediated target gene regulation (Chen et al., 2006; Choudhry et al., 2006) . This synergy is believed to be mediated by interdomain allosteric pathways that may involve the conformation flexibility of the NTD but through mechanisms that remain undefined experimentally (Hilser and Thompson, 2011) . Our limited proteolysis experiments further support HDX results and this hypothesis ( Figure 6 ).
Hormone agonists as well as the antagonist RU486 induce dimerization and binding of PR to consensus progesterone response element (PRE) DNA. However, PR bound to target DNA in the presence of RU486 has impaired transcription activity due to an altered conformation in PR that does not permit optimal recruitment of coregulatory proteins (Hill et al., 2012) . Ligand-dependent dimerization of PR in solution is thought to occur as a requisite step prior to DNA binding. Although controversial because the dimerization constant for purified PR in solution is in the mM range above the concentration of PR in most cells (Connaghan-Jones et al., 2006; Heneghan et al., 2005) , ligand-induced dimerization independent of DNA binding has been shown in cell-based assays (Carbajo et al., 1996; Hill et al., 2012; Tetel et al., 1997) . The PR dimer interface in the absence of DNA involves surfaces in both the NTD (Bain et al., 2001; Tetel et al., 1997) and the LBD (Williams and Sigler, 1998) . Crystal structure of the PR-LBD showed dimerization to be mediated by helices 10 and 11 (Williams and Sigler, 1998) , but sequences in the NTD have not been defined. An additional DNA-dependent dimerization interface is present in the DNA-binding domain that functions to stabilize receptor dimers upon binding DNA (Hill et al., 2012) . HDX analysis of full-length PRs in the present study was performed in the absence of DNA with purified PR in a dimeric form. Therefore, our results reflect conformational flexibility of preformed PR dimers and do not provide insight into dimerization process. HDX-MS experiments for analysis of solution dimerization will require isolation of PR monomers and in vitro conditions to promote monomer-dimer assembly. DNA interaction has been demonstrated to induce changes in structural conformation in either the NTD or LBD/AF2s of steroid receptors. Moreover, different target DNA sequences have been observed to induce distinct conformations, indicating DNA can act as a regulatory ligand for steroid receptors (Hill et al., 2012; Kumar and Thompson, 2012; Meijsing et al., 2009) . In the present study, we did not analyze the effect of DNA on conformational flexibility of PR. Studies focused on the effects of hormonal ligands and a protein-binding partner. It will be important to perform differential HDX-MS analysis of PR-DNA complexes to gain a more complete assessment of the structural state of transcriptionally active receptors.
Based on the results from the studies presented here, we developed a model for how TBP interaction with the flexible NTD can allosterically mediate structural rearrangement in the NTD and the LBD to potentially affect synergistic transcriptional activation between AF1 and AF2 modulated by ligand (Figure 7) . Although HDX-MS analysis was done only with PR dimers in solution, DNA is included in the model as the convention for PR as a sequence-specific DNA-binding transcription factor. Both hormone agonists and the antagonist RU486 are known to induce dimerization and binding of PR to progesterone response element DNA. Upon binding DNA PR recruits assembly of coregulatory proteins required for transcriptional activation and due to distinct conformations in PR, coregulators are different in the presence of hormone agonist and antagonist. HDX results provide information on potential allosteric regulation of LBD/AF2 through TBP-PR NTD interaction. In the presence of hormone agonist, TBP-PR interaction results in structural reorganization of both the NTD and LBD/AF2. In the presence of the antagonist RU486, TBP interaction resulted in a small destabilization of NTD and failed to mediate the interdomain communication that results in structural reorganization of LBD/AF2.
An emerging picture is that the entire SR-signaling spectrum involves allosteric interactions between AF1/NTD and AF2/LBD surfaces for coregulatory protein interactions. It has also been suggested that the tissue-specific residual activity of selective SRMs used to therapeutically target SRs is mediated primarily via AF1 and that the relative functional importance of AF1 may be decided by specific SRM-induced conformational changes in either LBD or transmitted allosterically to the NTD (Berry et al., 1990; Halachmi et al., 1994; Lonard and O'Malley, 2012; Simons, 2010; Wu et al., 2005) . Our present studies support this notion, as HDX analysis of RU486-bound full-length PR:TBP complex shows that antagonist both negates the TBP impact on AF2 flexibility and destabilizes a region within AF1/NTD that was not detected with intact PR occupied by hormone agonist (Simons et al., 2014 ; Figure 3 ). There is precedent for RU486 promoting a structural conformation in the AF1/NTD of PR distinct from that of hormone agonist. Partial agonist activity of RU486 mediated by a coactivator that binds the PR-DBD and allosterically affects NTD structure was shown to require sequence regions within NTD (aas 327-427) that are not required for functional coactivator response in the presence of hormone agonist (Wardell et al., 2010) .
The significance of these findings lies in the possibility of therapeutically targeting AF1/NTD surfaces directly or indirectly, by allosteric modulations, to achieve tissue-restricted effects. Because TBP is a common binding partner for AF1/ NTD of all SRs and does not bind to the AF2/LBD, yet leads to conformational changes in the AF2/LBD, we hypothesize that TBP-induced disorder-order transition opens AF1/NTD protein surfaces for its interactions with specific coactivators. Consistent with this concept, we previously reported that structural reorganization of AF1/NTD of both GR and PR induced by TBP, enhanced binding of SRC-1 to AF1/NTD, and TBP and SRC-1 acted synergistically to functionally stimulate AF1/NTD-dependent transcriptional activity (Khan et al., 2011; Kumar et al., 2013) . Further understanding the structural and functional consequences of the AF1/NTD-TBP interaction sites may provide potential avenues to modify both AF1 and AF2 activities simultaneously. This level of control is needed for additional selectivity to target cell-tissue-specific gene regulations in current endocrine-based therapies that could complement or replace existing SRMs' actions. Targeting ID proteins by small molecules/peptides to block protein-protein interactions is a rapidly evolving field, and the above findings suggest that compounds that bind to NTD/AF1 could be promising molecules for SR-based therapeutics (Dunker and Uversky, 2010; Ferreon et al., 2013; Simons et al., 2014) . Drugs have been defined that interfere with intrinsic disorder-to-order transition induced by a binding protein by directly interacting with ID regions of the transcription factor (Dunker and Uversky, 2010) . Meaningful screens for small molecules that could modify AF1/NTD-TBP binding may provide the additional selectivity needed to target SR-selective genes and thereby reduce the number of undesirable side effects in current endocrine-based cancers.
EXPERIMENTAL PROCEDURES
Reagents, Chemicals, and Purified Proteins High-performance liquid chromatography (HPLC)-grade H2O, D2O (9.9%), acetonitrile, formic acid, isopropanol, Tris, and NaCl was purchased from Sigma-Aldrich, and trifluoroacetic acid (TFA; sequanal grade) was obtained from Pierce. The procine pepsin-immobilized POROS 20 AL beads (Applied Biosystems) of particle size 20 mm were used to pack immobilized pepsin columns. Full-length PR-A and PR-B as well as isolated PR NTD domains were expressed from baculovirus vectors as recombinant proteins in Sf9 insect cells Both hormonal agonist and antagonist promote dimerization and binding of PR to progesterone response element (PRE) target DNA. Once DNA bound, receptor dimers assemble a multiprotein complex of coregulators, which differ for an agonist versus antagonist due at least in part to distinct conformations in the LBD/AF2. In the presence of agonist, TBP binding to the NTD results in conformational rearrangements in the NTD and in the LBD/AF2 through allosteric regulation. These structural rearrangements facilitate the binding and assembly of other coactivators at either LBD/AF2 or AF1 in the NTD. In the presence of antagonist, TBP binding with NTD resulted in a slight destabilization of NTD structure and the interdomain communication with LBD/AF2 was lost. and purified as previously described with >95% purity at a concentration range of 10-20 mM (Kumar et al., 2013; Wardell et al., 2005) . By sizeexclusion chromatography (S-200 column), purified full-length PR-A and PR-B fractionated as a single symmetrical peak with a retention volume consistent with that of a PR dimer. For isolation and purification of intact PR bound to either hormone agonist (R5020) or antagonist (RU486), ligands were added to Sf9 insect cell cultures for 24 hr prior to cell harvest as previously described (Wardell et al., 2005) . The C-terminal core DNA-binding domain (aas 159-339) of human TATA-binding protein (TBP c ) was expressed from a pET-21d bacterial expression vector and purified as previously described (Kumar et al., 2013) . Glutathione S-transferase-tagged PR-LBD (675-693) was purchased from Invitrogen (catalog no. P2899).
Hydrogen/Deuterium Exchange and Mass Spectrometry Solution-phase amide HDX was carried out with a fully automated system as described previously (Chalmers et al., 2006; Goswami et al., 2013) . Briefly, 4 ml of 10 mM full-length PR or PR constructs or TBP c was diluted to 20 ml with D 2 O-containing HDX buffer and incubated at 4 C for 10 s, 30 s, 60 s, 900 s, or 3,600 s. Following on exchange, unwanted forward or back exchange was minimized and the protein was denatured by dilution to 50 ml with 0.1% (v/v) TFA in 5 M urea (held at 1 C). Samples were then passed across an immobilized pepsin column at 50 ml min À1 (0.1% v/v TFA; 15 C); the resulting peptides were trapped on a C8 trap cartridge (Hypersil Gold; Thermo Fisher Scientific). Peptides were then gradient-eluted (4% [w/v] CH3CN to 40% [w/v] CH3CN and 0.3% [w/v] formic acid over 5 min at 2 C) across a 1 3 50 mm C18 HPLC column (Hypersil Gold; Thermo Fisher Scientific) and electrosprayed directly into an Orbitrap mass spectrometer (LTQ Orbitrap with ETD; Thermo Fisher Scientific). Peptide ion signals were confirmed if they had a MASCOT score of 20 or greater and had no ambiguous hits using a decoy (reverse) sequence in a separate experiment using a 60 min gradient. The intensity-weighted average m/z value (centroid) of each peptide's isotopic envelope was calculated with the in-house developed software (Pascal et al., 2012) and corrected for back-exchange on an estimated 70% recovery and accounting for the known deuterium content of the on-exchange buffer. To measure the difference in exchange rates, we calculated the average percentage deuterium uptake for say full-length PR following 10, 30, 60, 900, and 3,600 s of on exchange. From this value, we subtracted the average percent deuterium uptake measured for the TBP c -bound PR (at 5:1 molar ratio).
For back-exchange correction, experiments were repeated with full deuterium controls (run in triplicate). Proteins were diluted to 10 mM, predigested with pepsin offline, and incubated at 37 C for 16 hr with D 2 O containing HDX buffer with the same ratio as the above-mentioned HDX experiments. Then, 20 ml of aliquots were added to 30 ml of cold quench buffer and subsequent sample analysis was carried out in automated fashion as described for HDX samples (above), except no correction for estimated deuterium recovery was applied. Instead, the average percent deuterium values from each triplicate sample was divided by the average percent deuterium values from the full deuterium controls to correct for individual peptide back exchange.
Limited Proteolysis
Three sets of partial proteolytic experiments were carried out. In the first set, purified proteins (PR-A, PR-NTD, PR-LBD, TBP c , PR-A:TBP c , PR-NTD:TBP c , and PR-LBD:TBP c mixture) were digested by using trypsin (Promega). Digestions were carried out at 4 C for 15 min by using a protein:enzyme mass ratio of 100:1. Reactions were terminated by adding SDS loading buffer and placing the sample tubes in boiling water for 5 min. The proteolytic digestion products were resolved on SDS-PAGE followed by Coomassie blue R-250 staining. In the second set, following digestion of PR-A, PR-NTD, TBP c , and PR-A:TBP c and PR-NTD:TBP c mixtures, proteolytic digestion products were resolved on SDS-PAGE and proceeded with immunoblotting with PR-NTD-or LBDspecific antibodies. Mouse mAbs to human PR (clone no. 1294 and 636), which detect distinct epitopes in the NTD (Press et al., 2002) , and clone 10A9 (Immunotech) elicited against amino acids 922-933, which form the extreme C terminus of the human PR, were used to detect the peptide products of PR. In the third set, PR-LBD, TBP c , and PR-LBD:TBP c mixture were digested with trypsin at room temperature for 10, 15, and 20 min and proteolytic digestion products were resolved on SDS-PAGE followed by immunoblotting with PR-LBD-specific antibody (10A9).
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